SEMHAR MEKONEN: Open Payments
NPI 1205357654 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,253 in 55 payments from 13 companies in 2025. Trend: 2023 $1,583 · 2024 $1,216 · 2025 $2,253
Food & beverage: $2,253
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $551 |
| Regeneron Healthcare Solutions, Inc. | 7 | $357 |
| Janssen Biotech, Inc. | 8 | $227 |
| Botanix SB Inc | 6 | $206 |
| Galderma Laboratories, L.P. | 5 | $202 |
| Arcutis Biotherapeutics, Inc. | 1 | $124 |
| Lilly USA, LLC | 2 | $122 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $120 |
| UCB, Inc. | 4 | $112 |
| GENZYME CORPORATION | 4 | $111 |
Products named: DUPIXENT, BOTOX, TREMFYA, SOFDRA, NEMLUVIO, SKYRIZI, Zoryve, Winlevi.
Industry payments across FL — which companies pay providers there.
